Related Experiment Video
Updated: May 13, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound 30/45MHZ System
Published on: May 5, 2018
Update on Prenatal Detection Rate of Critical Congenital Heart Disease Before and During the COVID-19 Pandemic
Deepak Gupta1, Tiffany Vuong2, Shuo Wang3
1Children's Hospital Los Angeles, Department of Pediatrics, Los Angeles, California, USA.
Insights
Prenatal diagnosis of critical congenital heart disease (CCHD) improved during the COVID-19 pandemic. This study found higher odds of CCHD prenatal diagnosis during the pandemic, especially for single ventricle lesions and outflow tract anomalies.
Area of Science:
- Pediatric Cardiology
- Prenatal Medicine
- Public Health
Background:
- Prenatal diagnosis of critical congenital heart disease (CCHD) has seen improvements.
- Previous research identified CCHD subtype and socioeconomic status as key factors influencing prenatal diagnosis rates.
- The COVID-19 pandemic presented unique challenges and potential shifts in healthcare delivery.
Purpose of the Study:
- To compare prenatal diagnosis rates of newborns with CCHD during the COVID-19 pandemic (March 2020-March 2021) versus the pre-pandemic era.
- To identify factors associated with the lack of prenatal diagnosis for CCHD.
- To analyze trends in CCHD diagnosis rates compared to historical data (2009-2012 and 2013-2016).
Main Methods:
- Single-center retrospective study analyzing newborns admitted for cardiac intervention.
- Comparison of prenatal diagnosis rates between pandemic and pre-pandemic periods.
- Statistical analysis including adjusted odds ratios (aOR) to control for lesion type and identify significant associations.
Main Results:
- Patients had 2.17 times higher odds of CCHD prenatal diagnosis during the pandemic compared to the 2009-2012 pre-pandemic period (aOR = 2.17, p = 0.001).
- Single ventricle lesions (aOR 6.74) and outflow tract anomalies (aOR 2.20) showed the highest odds of prenatal diagnosis.
- Outflow tract anomalies had significantly higher odds for prenatal detection during the pandemic compared to 2009-2012 (aOR 2.01, p = 0.031).
Conclusions:
- Prenatal detection of CCHD among newborns requiring cardiac intervention appears to have improved during the COVID-19 pandemic.
- Specific CCHD subtypes, such as single ventricle lesions and outflow tract anomalies, demonstrated increased prenatal diagnosis rates.
- Further research is warranted to understand the underlying reasons for improved prenatal detection during the pandemic.
Abstract:
Prenatal diagnosis of critical congenital heart disease (CCHD) has improved over time, and previous studies have identified CCHD subtype and socioeconomic status as factors influencing rates of prenatal diagnosis. Our objective of this single-center study was to compare prenatal diagnosis rates of newborns with CCHD admitted for cardiac intervention from the COVID-19 pandemic period (March 2020 to March 2021) to the pre-pandemic period and identify factors associated with the lack of CCHD prenatal diagnosis. The overall rate of CCHD and rates of the various CCHD diagnoses were calculated and compared with historical data collection periods (2009-2012 and 2013-2016). Compared with the 2009-2012 pre-pandemic period, patients had 2.17 times higher odds of having a prenatal diagnosis of CCHD during the pandemic period controlling for lesion type (aOR = 2.17, 95% CI 1.36-3.48, p = 0.001). Single ventricle lesions (aOR 6.74 [4.64-9.80], p < 0.001) and outflow tract anomalies (aOR 2.20 [1.56-3.12], p < 0.001) had the highest odds of prenatal diagnosis compared with the remaining lesions. Patients with outflow tract anomalies had higher odds for prenatal detection in the pandemic period compared with during the 2009-2012 pre-pandemic period (aOR 2.01 [1.06-3.78], p = 0.031). In conclusion, prenatal detection of CCHD among newborns presenting for cardiac intervention appeared to have improved during the pandemic period.
More Related Videos
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Mitral Valve Prolapse III: Nursing Management
Mitral Stenosis II: Clinical features and Diagnostic Tests
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management

